Navigation Links
Criterion Gel Holder Cassettes 2

ProductsCriterion Gel Holder Cassettes 2
Company Bio-Rad Lab Equipment
Item Criterion Gel Holder Cassettes 2
Features Inquire
Description A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-use of the Mini Trans-Blot system.
Info Bio-Rad Lab Equipment
Customer Service: 510-741-5790
Web site: http://www.bio-rad.com/

Related medicine products :

1. Criterion™ II Urine Analyzer
2. Criterion Blotter w/ Plate Electrodes
3. Criterion Gel/Plate Blot System
4. Criterion Blotter w/ Wire Electrodes
5. Criterion Gel/Wire Blot System
6. Criterion Dodeca Cell
7. Microsurgical Cannula Holder Tray
8. Carter Sphere Introducer and Holder
9. Micro Needle Holders Round Handles
10. Micro Needle Holders With Lock
11. Malis Needle Holders
Volume: 5 ml; Volume Graduation: 1/10 ml...
Precise, safe, and fatigue-free series pipetting using graduated pip...
An adhesive-backed hanger, designed for use where space is limited (fume hoods, sterile hoods, etc.). Sticks to any smooth, dry surface without damage. Resistant to chemicals and UV light....
Inquire...
Medicine Products:
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... ... Convenient Healthcare and Pharmacy Collaborative for retail healthcare providers begins in Kissimmee, ... pharmacists, nurse practitioners and physician assistants can work together to expand access to ...
(Date:7/29/2015)... ... 29, 2015 , ... Abt Associates has named Selena Ramkeesoon, ... In her position, Ramkeesoon will help build and expand work in communications, ... close to a decade at ICF International, most recently as a vice president. ...
(Date:7/29/2015)... ... 2015 , ... According to the The Media Post on July ... advertisements, for medicinal use are more likely to abuse the substance. A recent study ... is considered beneficial are more apt to use the substance, as opposed to their ...
(Date:7/29/2015)... ... July 29, 2015 , ... The report “Atherosclerosis - Pipeline ... is a slow, progressive disease that may start in childhood. The report strengthens ... products. Complete report on Atherosclerosis Pipeline with 78 market data tables and 15 ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Commission) CCM® credential for a five-year period, expiring November 30, 2019, during its ... credential by submitting an application demonstrating the program’s compliance with the NCCA’s Standards ...
Breaking Medicine News(10 mins):Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 2Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 3Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 4Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3
... Baldrige National Quality Award Recipient & Magnet ... for Leveraging Patient Engagement to Improve Hospital ... second annual users conference hosted by GetWellNetwork, ... Care (IPC) solution, will bring together physicians, ...
... CUREXO Technology Corporation, pioneer in medical robotics and ... applications, which is focused on marketing its robotic ... premarket notification 510(k) application to the U.S. Food ... the U.S. for use of its ROBODOC(R) Surgical ...
... IRVINE, Calif., Feb. 25 Already a ... of Enterprise Brand Intelligence software, is now offering its ... Momentum CEO, reported, "According to the Center for Medicine ... at about 13 percent annually -- nearly twice the ...
... from bioabsorbable Hydroxyapatite (HA)ANDOVER, Mass., Feb. 25 Smith ... Endoscopy Division has announced the launch of the OSTEORAPTOR ... device is showcased at the American Academy of Orthopaedic ... Vegas.During 2009, surgeons will perform an estimated 15,000 labral ...
... Study suggests jobs such as baby-sitting, lawn mowing could spell ... study suggests it,s possible that too much work might turn ... fifth-graders who worked the most at jobs such as baby-sitting ... and get into fights. , The findings don,t prove that ...
... efforts include the re-alignment of shared services, ... Governance and Medical Device Governance CommitteesROCKVILLE, Md. ... America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical ... restructuring initiatives as part of the North ...
Cached Medicine News:Health News:GetWellNetwork Announces GetConnected2009 2Health News:GetWellNetwork Announces GetConnected2009 3Health News:CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application 2Health News:New Momentum Launches Anti-Counterfeiting Software for Pharmaceutical Companies 2Health News:Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder 2Health News:Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder 3Health News:Smith & Nephew Endoscopy's OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder 4Health News:Work May Not Be Best for Young Kids 2Health News:Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide 2Health News:Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide 3
(Date:7/29/2015)... , July 29, 2015 Varian Medical Systems, Inc., ... one of its European subsidiaries, agreed to acquire Claymount, ... components and subsystems for X-ray imaging equipment manufacturers. Varian,s subsidiary ... approximately €50 million in cash for Claymount. The transaction ... Claymount is one of the world,s leading suppliers ...
(Date:7/29/2015)... , July 29, 2015 Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that it ... Monday, August 10, 2015 after the close of the ... call and webcast on Monday, August 10, 2015 at ... the results and corporate developments. For both ...
(Date:7/29/2015)... -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP ) announced today ... million through two financing agreements. The first, with Hercules ... a term loan of up to $9.5 million. The ... for the sale to Discover of newly created Series ... to $12 million in gross proceeds to the company. ...
Breaking Medicine Technology:Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7